(Q70409076)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Therapy of cutaneous lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

cutaneous lupus erythematosus

11 October 2019

main subject

1 reference

J P Callen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 July 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

795-805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

Cutaneous bullae following acute steroid withdrawal in systemic lupus erythematosus

11 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Subacute cutaneous lupus erythematosus and porphyria cutanea tarda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

An unusual variant of lupus erythematosus or lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Systemic Lupus Erythematosus Presenting as Panniculitis (Lupus Profundus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Antimalarials in the management of discoid and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Systemic lupus erythematosus changing to the chronic discoid type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Serological findings in patients with "ANA-negative" systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Antimalarials and ophthalmologic safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

A study of lupus erythematosus with particular reference to generalized discoid lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Herpetiform Blisters in Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Ophthalmologic safety of long-term hydroxychloroquine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Subacute Cutaneous Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Hydroxychloroquine. Seven-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Lupus erythematosus panniculitis (profundus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

CUTANEOUS MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Systemic lupus erythematosus with anti-Ro antibodies: clinical, histologic and immunologic findings. Report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

Internal disorders associated with bullous disease of the skin. A critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931394-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)31394-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7098619%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference